Diabetes Complications at Presentation and One Year by Glycated Haemoglobin at Diagnosis in a Multiethnic and Diverse Socioeconomic Population: Results from the South London Diabetes Study
Table 1
Comparisons between participants diagnosed with HbA1c < 48 mmol/mol and with HbA1c ≥ 48 mmol/mol at diagnosis and recruitment.
with data
HbA1c < 48 mmol/mol (6.5%)
HbA1c ≥ 48 mmol/mol (6.5%)
value
Demographical data
Age
1488
58.73 (±10.36)
54.87 (±11.07)
<0.0001
Gender (% male)
1488
188 (55.46)
632 (55.00)
0.8829
Ethnicity (%)
1488
White
218 (64.31)
528 (45.95)
<0.0001
Black
98 (28.91)
491 (42.73)
Asian
23 (6.78)
130 (11.31)
Median (IQR) HbA1c at diagnosis
HbA1c (mmol/mol)
1488
44.26 (42.08–45.35),
58.47 (51.91–82.52)
<0.0010
HbA1c (%)
6.20 (6.00–6.30)
7.50 (6.90–9.70)
Cardiovascular risk factors (SD) at diagnosis
LDL-C (mmol/L)
1211
2.86 (±0.98)
3.67 (±21.83)
0.5313
HDL-C (mmol/L)
1251
1.28 (±0.67)
1.24 (±0.44)
0.1750
Total cholesterol (mmol/L)
1357
4.70 (±1.32)
4.90 (±1.50)
0.0053
Triglycerides (mmol/L)
1273
1.40 (±0.85)
1.59 (±1.29)
0.0001
BMI (kg/m2)
1380
30.77 (±7.74)
31.60 (8.40)
0.0035
BPS (mmHg)
1409
133.96 (±16.84)
134.65 (±16.28)
0.5087
BPD (mmHg)
1409
80.00 (±11.00)
82.00 (±12.00)
<0.0001
Complication status, HbA1c medication status at recruitment